1. Acknowledgement to Referees

   Acknowledgement to Referees 19 December 2022 Pages: 1 - 4

2. Complement Inhibition in Kidney Transplantation: Where Are We Now?

   • Eva Vonbrunn
   • Maike Büttner-Herold
   • Christoph Daniel

   Current Opinion Open access 13 December 2022 Pages: 5 - 19

   

3. Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy

   • Dafne Müller

   Review Article Open access 26 December 2022 Pages: 21 - 33

   

4. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

   • Yuxiong Jiang
   • Youdong Chen
   • Yuling Shi

   Review Article Open access 02 January 2023 Pages: 35 - 55

   

5. Current Developments in the Preclinical and Clinical use of Natural Killer T cells

   • Christina Kratzmeier
   • Sasha Singh
   • Tonya J. Webb

   Review Article 16 December 2022 Pages: 57 - 71

   

6. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase^®)

   • Amandine Dernoncourt
   • Sophie Liabeuf
   • Benjamin Batteux

   Original Research Article Open access 19 November 2022 Pages: 73 - 87

   

7. Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial

   • Min Wu
   • Xiaojiao Li
   • Yanhua Ding

   Original Research Article 22 November 2022 Pages: 89 - 98

   

8. Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations

   • Kenta Haraya
   • Tatsuhiko Tachibana

   Original Research Article Open access 30 November 2022 Pages: 99 - 108

   

9. Malaysian Hospital Pharmacists’ Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey

   • Noraisyah Mohd Sani
   • Zoriah Aziz
   • Adeeba Kamarulzaman

   Original Research Article 26 December 2022 Pages: 109 - 120

   

10. Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

    • Maxime Boussageon
    • Aurélie Swalduz
    • Olivier Bylicki

    Correction 19 November 2022 Pages: 121 - 121